Related Experiment Video
Updated: Apr 25, 2026

13:21
Graphene Coatings for Biomedical Implants
Published on: March 1, 2013
20.8K
Nitinol-based nanotubular coatings for the modulation of human vascular cell function
Phin P Lee1, Alec Cerchiari, Tejal A Desai
1Department of Bioengineering and Therapeutic Sciences, University of California-San Francisco , San Francisco, California 94158, United States.
Nano Letters
|August 14, 2014
Summary
This study developed a nanotubular coating for Nitinol implants. The coating enhances endothelial cell function and reduces smooth muscle cell proliferation, potentially improving stent performance and reducing restenosis.
Area of Science:
- Biomaterials Science
- Surface Engineering
- Medical Device Technology
Background:
- Nitinol (Nickel-Titanium alloy) is widely used in medical implants due to its superelasticity.
- Current Nitinol implants face challenges like restenosis and limited biocompatibility.
- Surface modification is crucial for enhancing the performance of Nitinol-based devices.
Purpose of the Study:
- To synthesize and characterize an upright nanotubular coating on Nitinol.
- To evaluate the coating's effect on endothelial cell behavior for improved re-endothelialization.
- To assess the coating's impact on smooth muscle cell proliferation and inflammation for reduced neointimal hyperplasia.
Main Methods:
- Anodization technique used to create upright nanotubular structures on Nitinol.
- Surface elemental composition and nickel ion release rates were characterized.
- In vitro studies using primary human aortic endothelial cells (HAECs) and human aortic smooth muscle cells (HASMCs) were performed.
Main Results:
- The nanotubular coating successfully formed discrete, exposed nanotubes on Nitinol.
- Enhanced cell spreading and migration of HAECs were observed on the nanotubular surface.
- Reduced proliferation and collagen I/MMP-2 expression in HASMCs were noted, indicating reduced neointimal hyperplasia.
- No significant increase in ICAM-1 expression (inflammation marker) was observed in HASMCs compared to controls.
Conclusions:
- The developed nanotubular coating improves Nitinol biocompatibility by promoting endothelialization and reducing smooth muscle cell response.
- This surface modification strategy shows potential for reducing restenosis rates in Nitinol stents.
- The coating offers a generalized approach for enhancing various Nitinol-based medical devices.

